Article info
PDFCurrent controversy
Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR
- Correspondence to Dr Shawna Benston, 108 East 96th Street, Apt. 9E, New York, NY 10128, USA; Shawna.benston{at}gmail.com
Citation
Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR
Publication history
- Received May 6, 2016
- Revised March 28, 2017
- Accepted April 17, 2017
- First published May 4, 2017.
Online issue publication
November 23, 2017
Article Versions
- Previous version (4 May 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Gene editing as a promising approach for respiratory diseases
- Science fiction authors’ perspectives on human genetic engineering
- Sport and exercise genomics: the FIMS 2019 consensus statement update
- Gene editing for inflammatory disorders
- Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia
- Applications and advances of CRISPR-Cas9 in cancer immunotherapy
- A refined method to study gene dosage changes in vitro using CRISPR/Cas9
- Scientists call for moratorium on editing heritable genes
- CBLB ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy
- CRISPR-Cas9 for medical genetic screens: applications and future perspectives